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impact of child gastroenteritis on parents. METHODS: A litera-
ture review was conducted to create the ﬁrst conceptual model.
Semi-directive interviews of 10 parents were conducted and
analysed to create items. A 54-item self-administered question-
naire was simultaneously developed in French and UK English
and cognitive debrieﬁngs were conducted with 5 parents. The
questionnaire was linguistically validated in Spanish, Italian and
Polish and included in an observational and prospective study
conducted with 302 parents of children under 5 presenting at the
general practitioner/paediatrician site with acute gastroenteritis.
Multitrait analysis and item content were used to conﬁrm the
dimensions and deﬁne the scoring of the questionnaire. Internal
consistency reliability (Cronbach’s alpha), ﬂoor and ceiling
effects, scale-scale correlations and criterion validity of the result-
ing version were assessed. RESULTS: The ﬁnal version of the
questionnaire consists of 44 items in ﬁve dimensions: “Symptom
Severity” (13 items), “Parents’ Worries due to Symptoms” (8
items), “Child’s Behaviour” (6 items), “Impact on Parents’ Daily
Activities” (10 items) and “Parents’ Distress” (7 items). Higher
scores indicate higher levels of negative feelings. All the scores
presented good psychometric properties: no dimension had a
ﬂoor or ceiling effect, Cronbach’s alpha ranged from 0.78 to 0.85
showing a good internal consistency reliability, and scale-scale
correlations ranged from 0.41 to 0.67 showing consistency but
no redundancy between the dimensions. Correlations with
Clark’s and Vesikari’s scores showed a good criterion validity.
The more severe the gastroenteritis episode, the higher the scores
of the questionnaire. CONCLUSIONS: The “Impact of child
gastroenteritis on parents” questionnaire allows a very complete
overview of how an episode of severe gastroenteritis impacts the
parents of the ill child. The questionnaire is a valid and reliable
instrument, suitable for future studies.
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OBJECTIVES: To compare the ability of individual and societal
preference scores based on the EQ-5D to identify active inﬂam-
matory bowel disease (IBD) in Germany. METHODS: Members
of the German IBD Association documented Health-Related
Quality of Life (hrQoL) with the EQ5-D and other disease-
related factors. Inactive or active disease was based on calculated
IBD activity indices. Disease activity was also classiﬁed (present
or absent) according to sick-leave and hospitalizations, docu-
mented retrospectively (three months) and prospectively (four
weeks). EQ-5D index scores were calculated using British (EQ-
5DBT) and German (EQ-5DGT) tariffs. Differences in EQ VAS
and EQ-5D index scores between patient groups differing in
disease activity, sick-leave and hospitalizations were determined
by effect size (ES) and bootstrap test for the standardised differ-
ence between the means. ES and bootstrap-test probability are
always reported in this consecutive order: EQ VAS, EQ-5DBT
and EQ-5DGT. RESULTS: A total of 527 retrospective and 483
prospective questionnaires were analysed. Retrospectively, 20%
reported sick-leave, 7% hospitalisation, whereas prospectively,
12% reported sick-leave, 2% hospitalisation. 39% had active
disease. All preference scores differed signiﬁcantly between
patients with active and inactive disease (ES: 13.72, 11.47, 9.56;
p: 0.0001(all)). Retrospectively, ES of preference scores of
patients differing in sick-leave (ES: 4.35, 4.51, 3.37; p: 0.0001,
0.0001, 0.002) and hospitalisation (ES: 2.07, 2.17, 1.91; p:
0.047, 0.047, 0.081) were large. Prospectively, the ES of prefer-
ence scores for sick-leave groups (ES: 4.34, 4.32, 3.00; p: 0.0001,
0.0002, 0.0119) and hospitalisation (ES: 3.45, 3.08, 2.50;
p: 0.014, 0.022, 0.061) were also large. CONCLUSIONS: In
German IBD subjects, the ES of all preference scores was large
regarding disease-activity, sick-leave and hospitalisation both ret-
rospectively and prospectively. Bootstrap-test probability showed
that the EQ-5DGT discriminated less well between the groups
than the other preference scores.
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OBJECTIVES: Limited epidemiological data are available con-
cerning gastroesophageal reﬂux disease (GERD). The aims of
this study were to estimate the proportion of patients with
GERD-related symptoms in primary care, and to describe the
symptom burden and clinical management of the disease.
METHODS: RANGE-Greece was part of a European pro-
gramme, which was conducted in six countries and comprised
similar cross-sectional studies run in parallel. RANGE-Greece
recruited retrospectively identiﬁed patients who visited an ofﬁce-
based gastroenterologist for a GERD-related reason during a
4-month period (index visit). Consenting subjects were invited to
attend a study visit. Data collection was performed for both the
index and study visits. Patient-reported outcomes were collected
by means of validated questionnaires (RDQ, XQS, GIS, WPAI-
GERD). RESULTS: From the 29,903 patients identiﬁed by 23
gastroenterologists, 2116 (7.1%) had GERD-related reasons for
the index visit. 505 randomly selected patients, who consented
to participation, comprised the analysed population. Mean
(SD) age was 52 (14) years; 52.5% were women. The main
reasons for the index visit were: recurrent symptoms after a
remission period (41.8%), new reﬂux symptoms in a treatment-
naïve patient (35.6%), persistence of previous reﬂux symptoms
(10.9%), and follow-up visit in an asymptomatic patient (5.5%).
57.4% of patients had an endoscopic diagnosis. At the index
visit, 99.8% of patients were prescribed a proton pump inhibi-
tor. The study visit was performed after a median of 6.5 months.
A total of 40.6% of patients had not changed treatment,
whereas 23.6% and 21.0% were still suffering from heartburn
and acid regurgitation, respectively (frequency 2 days the pre-
vious week). Symptom severity was moderate in 29.3% and
22.8% and severe in 3.2% and 4.2% of patients with heartburn
and acid regurgitation, respectively. CONCLUSIONS: Despite
medical attention and treatment a considerable proportion of
patients did not achieve an acceptable control of GERD-related
symptoms.
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OBJECTIVES: GERD is associated with obesity, age and gender
in several studies. The GERD impact scale is a validated one-page
self-administered questionnaire that asks patients about GERD
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symptoms and its impact in their lives.We aimed to describe
if there are some differences in frequency and impact of GERD
symptoms in their lives depending on gender, age and body mass
index (BMI) measured by GIS. METHODS: The data evaluated
in this cross-sectional study were recorded by 1170 primary care
physicians, randomly distributed across the country, from 5735,
new or previously diagnosed GERD patients who consulted
about GERD symptoms in Primary Care Setting. The patients
ﬁlled the GIS questionnaire at the doctors’ ofﬁce in the study
visit. Data regarding sociodemographic variables, comorbidities
co-medications, symtomps and treatment were collected by the
primary care physician during the study visit. The GIS results
were scored, using a four-graded Likert scale, from 1 (daily) to 4
(never) (the higher value the better is the patient) and the ques-
tionnaire was divided in three categories (upper GI symptoms,
other acid related GI symptoms and impact of symptoms). Com-
parisons between the global GIS index and each of the dimen-
sions were performed with an ANCOVA model, adjusting for the
confusing variables: gender (male/female), BMI (under or over
30 kg/m2) and age (under or over 50 years old). RESULTS: The
global GIS mean score in the 5735 patients was 2.8. The
adjusted-mean was higher in the female (2.82) versus male (2.77)
gender (p = 0.0119) and in the non-obese (2.83) versus obese
(2.75) patients (p < 0,0001). There were no differences in the
adjusted-mean depending on age (p = 0.0568). The female
patients had a higher score in the adjusted-means of “other acid
related GI symptoms” (p = 0.0163) and “impact of symptoms”
(p = 0,01) categories but not in the “upper GI symptoms”
(p = 0.0746). The age was only associated with “other acid
related symptoms” category. The adjusted-mean score in this
category was higher in patients under 50 years old (p = 0.0132).
The obesity was associated with lower scores in the three cat-
egories (p = 0.0085, p = 0.0016 and p < 0.0001 respectively).
CONCLUSIONS: The use of the self-administered GIS tool in
patients who consulted in the PCS showed the GERD symptoms
are more frequent and have more impact in male and obese
patients, as previous population-based studies have concluded.
The age has an inﬂuence only in the frequency of a small pro-
portion of symptoms and not in the impact of GERD in patients’
everyday lives.
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OBJECTIVES: The diagnosis of upper GI disorders is based on
symptoms or endoscopic ﬁndings. This study evaluated whether
the severity and frequency of upper GI symptoms correlate with
endoscopic ﬁndings. METHODS: This was a single visit cross-
sectional study, regarding primary care patients with upper GI
symptoms and recent endoscopy data. Investigators (gastroenter-
ologists) recorded demographic data, medical history and endo-
scopic ﬁndings. Frequency and severity of GERD (heartburn/
regurgitation) and dyspeptic symptoms (epigastric pain/early
satiety/postprandial fullness) were recorded by a patient
questionnaire. RESULTS: A total of 112 investigators recruited
1120 patients (male/female: 604/516, mean age: 50 years, mean
BMI: 27 kg/m2) in two periods (November–December 2006 and
June–September 2007). Upper GI symptoms for 2 days in the
last week were reported by 98% of patients (GERD: 71%, Dys-
pepsia: 76%). Symptoms were present for 3–5 and 6–7 days/
week in 51% and 30% of patients, respectively, and were mild,
moderate or severe in 14%, 57% and 28% of patients, respec-
tively. The predominant endoscopic ﬁndings were peptic ulcer
(26%), esophagitis (43%), gastritis (14%) and hiatus hernia
(5%). In these groups, upper GI symptoms were present for 3
days/week in 83%, 83%, 79% and 71% of patients, respectively,
and were moderate/severe in 88%, 88%, 81% and 84%, respec-
tively. Among patients with esophagitis, GERD symptoms were
present for3 days/week in 47%, 56%, 63% and 86% and were
moderate-to-severe in 68%, 95%, 100% and 100% of cases with
LA grade A, B, C and D, respectively. CONCLUSIONS: The
majority of patients with upper GI symptoms visiting gastroen-
terologists have frequent (98%) and moderate-to-severe (86%)
symptoms. The severity and frequency of symptoms may be
affected by the severity of endoscopic ﬁndings. However, they
cannot be used as predictors of endoscopic ﬁndings, because
frequent and moderate-to-severe symptoms are reported not only
by most patients with more severe but also most of those with
milder endoscopic ﬁndings.
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OBJECTIVES: According to the Montreal deﬁnition gastroe-
sophageal reﬂux disease (GERD) develops when reﬂux causes
troublesome symptoms. Mild symptoms on 2 days a week or
moderate/severe symptoms on 1 day a week are associated
with reduced quality of life and are considered troublesome.
Objectives were to assess impact and cost of reﬂux symptoms
in the general population on work productivity and to evaluate
if troublesome symptoms is associated with signiﬁcantly larger
work productivity loss. METHODS: Members of a web-panel
responding to an e-mail invitation (1623/3506, median age
interval 40–44 yr, 51% female) were linked to screening ques-
tions on employment status and any reﬂux symptom during the
preceding 4 weeks. Employed respondents (n = 1284) reporting
reﬂux symptoms were linked to the full questionnaire (23 ques-
tions). Troublesome symptoms were deﬁned as mild symptoms
2 days/week or moderate/severe symptoms 1 day/week.
Work productivity impairment was quantiﬁed with the
GERD-speciﬁc Work Productivity and Activity Impairment
questionnaire (WPAI-GERD). Overall productivity losses were
converted into monetary cost using the human capital method.
RESULTS: Weekly or daily reﬂux symptoms were reported by
32% (408/1284). Of these 408 respondents, 266 had trouble-
some symptoms. Mean productivity loss pr. subject with
troublesome reﬂux symptoms (N = 266): absenteeism 2.1%
(€28/week); presenteeism 18% (€203/week); overall loss 18.1%
(€205/week). This was signiﬁcantly higher than in the group
with not troublesome symptoms (n = 142) reporting absentee-
ism of 0.1% (p = 0.01), presenteeism of 5.7% (p < 0.001) and
overall loss of 5.3% (p < 0.001). The proportion of subjects
with troublesome symptoms reporting productivity loss was
signiﬁcantly higher compared to subjects with not troublesome
reﬂux symptoms: ((10% vs. 3%; p = 0.01) and (62% vs. 37%;
p < 0.001)). Troublesome symptoms were associated with an
increased risk of productivity impairment with an OR of 3.1
(95% CI, 2.0–4.7). CONCLUSIONS: Categorizing reﬂux
symptoms as troublesome based on frequency and severity of
symptoms identiﬁes subjects with more marked impact on
work performance.
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